COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Featured ArticlesLatest NewsPsoriasisImpact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol
August 21, 2026

Impact of Intermittent Fasting, Keto Diet vs Continuous Caloric Restriction on Psoriasis Severity: A Systematic Review and Meta-Analysis Protocol

Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
Journal of Drugs in Dermatology JDD featuring The State of Sunscreens in the US: Caveat EmptorFeatured ArticlesLatest NewsPhotoprotectionThe State of Sunscreens in the US: Caveat Emptor
August 20, 2026

The State of Sunscreens in the US: Caveat Emptor

From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor  With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden.Featured ArticlesLatest NewsMedical DermPsoriasisJDD Re:View With Dr. Beer
August 19, 2026

JDD Re:View With Dr. Beer

Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…

Leave a Reply